🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial is studying eflornithine and sulindac to se...
Status
Completed
Location
University of California Medical Center At Irvine-Orange Campus
Start Date
1998-07
Trial ID
NCT00118365
Treatments Being Tested
This randomized phase II trial studies how well giving celecoxib with or wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2001-12-13
Trial ID
NCT00033371
Treatments Being Tested
A clinical study of the efficacy of oral alpha-difluoromethylornithine (efl...
Status
Completed
Location
Ministry of Health, Hospital de Occidente
Start Date
2016-09-19
Trial ID
NCT02794428
Treatments Being Tested
The purpose of this randomized, double-blind, Phase III trial is to determi...
Status
Completed
Location
University of California San Diego
Start Date
2013-10
Trial ID
NCT01483144
Treatments Being Tested
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to pr...
Status
Completed
Location
University of Texas - MD Anderson Cancer Center
Start Date
1998-06-19
Trial ID
NCT00006079
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as eflornithine, work in differ...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2001-11
Trial ID
NCT00086736
Treatments Being Tested
The goal of this clinical trial is to test a drug known as DFMO in people w...
Status
Active Not Recruiting
Location
Barbara Davis Center
Start Date
2023-03-14
Trial ID
NCT05594563
The purpose of this phase III study is to evaluate the safety and efficacy ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01245816
Treatments Being Tested